Cell lineage marker | Reagent Source | Surface antigen | RFI pre-priming, mean +/- SD (% positive) | RFI Post priming, mean +/- SD (% positive) |
---|---|---|---|---|
Leukocyte | BD | CD45 (pan leukocyte) | 6.3 +/- 1.1 (0%) | 5.4 +/- 0.7 (0%) |
 | BD | CD14 (macrophage) | 8.3 +/- 2.1 (0%) | 6.2 +/- 1.4 (0%) |
 | BD | CD3 (T Cell) | 5 +/- 0.2 (0%) | 6.1+/- 1.6 (0%) |
 | BD | T cell receptor (T Cell) | 6.3 +/- 1.4 (0%) | 4.5 +/- 1.1 (0%) |
 | BD | CD19 (B cell) | 6.8 +/- 0.7 (0%) | 7.4 +/- 1.6 (0%) |
 | BD | Immunoglobulin (B Cell) | 7.9 +/- 2.3 (0%) | 7.6 +/- 3.1 (0%) |
 | BD | CD13 (myeloid lineage) | 8 +/- 2.4 (0%) | 5.5 +/- 2.1 (0%) |
Endothelium | BD | CD31 | 5.9 +/- 2.2 (0%) | 6.1 +/- 3.1 (0%) |
Fibroblast | BD | CD104a | 4.7 +/- 1.1 (0%) | 5.1 +/- 2.4 (0%) |
 | BD | CD104b | 6.2 +/- 2.4 (0%) | 7.3 +/- 3.2 (0%) |
Chemokine | BD | CXCR4 | 1236.2 +/- 362.2 (92.1 +/5.8%) | 1422.1 +/- 303.2 (86.1 +/- 8.3%) |
 | BD | CXCR3 | 7.2 +/- 3.3 (0%) | 6.2 +/- 2.7 (0%) |
 | BD | CCR5 | 8.2 +/- 3.2 (0%) | 7.1 +/- 2.7 (0%) |
Stem cell | BD, CH | SSEA-1 | 93 +/- 5.5 (35.2 +/- 5.2%) | 5.4 2 +/-0.5 (5.4 +/- 1.6%)** |
 | BD, CH | SSEA-4 | 206.7 +/63 (41.5+/-6.9%) | 5.39 +/- 0.7(0%)** |
 | BD | CD34 | 6.1 +/- 2.8 (0%) | 7.2 +/- 3.4 (0%) |
 | SCT | ABCG2 | 670.9 +/- 38.7 (84.9 +/- 5.4%) | 127.3 +/- 35.4 (31.5 +/- 5.7%)** |
 | MIL, BD | CD133 | 688.8 +/- 63 (95.1+/- 2%) | 127.8 +/- 7.4 (39.2 +/- 7.8%)** |
 | BD | CD105 | 1892 +/- 49 (93& +/- 22) | 855 +/- 34 (86 +/- 14%)* |
 | BD | CD90 | 1568 +/- 42 (96% +/- 54) | 544 +/- 22 (74 +/-11)** |
 | BD | CD29 | 446 +/- 22 (85% +/-16%) | 349 +/- 56 (61 +/- 22%) |
Human Leukocyte Antigens | BD | MHC Class-1 (human) | 38.6 +/- 8 (35+/- 6.2%) | 59.5 +/-10 (59.4+/- 7.2%) |
 | BD | MHC Class II | 11.3 +/- 3.79 (0%) | 12.2 +/- 3.7 (0%) |
Neuronal Markers | CH | Nestin | 11.3 +/- 3.9 (0%) | 143.7 +/- 42 (23.1 +/- 4.4%)* |
 | CH | Map-1B | 11.3 +/- 3.9 (0%) | 139.3 +/- 44. 2(16+/- 2.9%)* |
 | CH, DAKO | GFAP | 4.2 +/- 1.6 (0%) | 7.4 +/- 1.7 (0%) |
 | CH | Tuj1 | 2.6 +/- 1.1 (0%) | 18.5 +/- 2.4 (3.4+/- 1.6%) |
 | CH, CST | TH | 2.7 +/- 0.8(0%) | 6.2 +/- 2.4 (2.1+/- 0.5%) |